{"paper_id":"a9478a6c-e54e-4a30-8401-1e62ae5c01b6","body_text":"Abstract\nAlterations in the microbiome composition have been identified in common gynecologic pathologies such as endometriosis carving a new frontier in diagnosis and treatment. We aimed to examine the existing literature on perturbations in the reproductive tract microbiome of individuals with adenomyosis informing future therapeutic targets. To examine the association between the reproductive tract microbiome composition among individuals with adenomyosis when compared to controls that can lead to new research evaluating novel mechanisms of action and treatment modalities. A systematic literature search identified studies that compared differences in microbiome composition using culture-independent microbiome analysis between individuals with adenomyosis when compared to controls. Five observational cross-sectional studies characterizing the lower and upper reproductive tract in humans were included. The diagnostic criteria of adenomyosis included surgical and imaging-based criteria. All studies used a 16S rRNA sequencing method. All individuals were recruited from either China or Thailand. An association between adenomyosis and alterations in the microbiome composition included relative deficiencies in Lactobacillus and relative enrichment of anaerobic and gram-negative bacteria when compared to control participants. Comparative studies suggest that there are significant perturbations in the microbiota composition of individuals with adenomyosis when compared with controls. Limiting conclusions include relative small sample sizes, a homogeneous population, and scant clinical phenotypic data. This systematic review identified significant alterations in the bacterial composition of adenomyosis cases that can be leveraged to design mechanistic studies and future innovative approaches to diagnose and manage this pathology. Trial registration: PROSPERO (CRD42023494563). Registered December 28, 2023.\nSimilar content being viewed by others\nData Availability\nData will be made available to the editors of the journal for review or query upon request.\nCode Availability\nNot applicable.\nReferences\nFerenczy A. Pathophysiology of adenomyosis. Hum Reprod Update. 1998;4(4):312–22.\nLoring M, Chen TY, Isaacson KB. A systematic review of adenomyosis: it is time to reassess what we thought we knew about the disease. J Minim Invasive Gynecol. 2021;28(3):644–55.\nLuciano DE, Exacoustos C, Albrecht L, et al. Three-dimensional ultrasound in diagnosis of adenomyosis: histologic correlation with ultrasound targeted biopsies of the uterus. J Minim Invasive Gynecol. 2013;20:803–10.\nVan den Bosch T, Dueholm M, Leone FP, Valentin L, Rasmussen CK, Votino A, Van Schoubroeck D, Landolfo C, Installé AJ, Guerriero S, Exacoustos C, Gordts S, Benacerraf B, D’Hooghe T, De Moor B, Brölmann H, Goldstein S, Epstein E, Bourne T, Timmerman D. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46(3):284–98.\nTellum T, Nygaard S, Lieng M. Noninvasive diagnosis of adenomyosis: a structured review and meta-analysis of diagnostic accuracy in imaging. J Minim Invasive Gynecol. 2020;27(2):408-418.e3.\nPinzauti S, Lazzeri L, Tosti C, Centini G, Orlandini C, Luisi S, Zupi E, Exacoustos C, Petraglia F. Transvaginal sonographic features of diffuse adenomyosis in 18–30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015;46(6):730–6.\nLeyendecker G, Bilgicyildirim A, Inacker M, et al. Adenomyosis and endometriosis. Re-visiting their association and further insights into the mechanisms of auto-traumatization. An MRI study. Arch Gynecol Obstet. 2015;291:917–32.\nKhan KN, Fujishita A, Kitajima M, Hiraki K, Nakashima M, Masuzaki H. Intra-uterine microbial colonization and occurrence of endometritis in women with endometriosis†. Hum Reprod. 2014;29(11):2446–56. https://doi.org/10.1093/humrep/deu222.\nZhai J, Vannuccini S, Petraglia F, Giudice LC. Adenomyosis: mechanisms and pathogenesis. Semin Reprod Med. 2020;38(2–03):129–43. https://doi.org/10.1055/s-0040-1716687.\nNagpal J, Cryan JF. Microbiota-brain interactions: moving toward mechanisms in model organisms. Neuron. 2021;109(24):3930–53.\nPelzer ES, Allan JA, Waterhouse MA, Ross T, Beagley KW, Knox CL. Microorganisms within human follicular fluid: effects on IVF. PLoS One. 2013;8(3):e59062.\nBenner M, Ferwerda G, Joosten I, van der Molen RG. How uterine microbiota might be responsible for a receptive, fertile endometrium. Hum Reprod Update. 2018;24(4):393–415. https://doi.org/10.1093/humupd/dmy012.\nFricke WF, Ravel J. Microbiome or no microbiome: are we looking at the prenatal environment through the right lens? Microbiome. 2021;9(1):9.\nKhan KN, Fujishita A, Hiraki K, Kitajima M, Nakashima M, Fushiki S, Kitawaki J. Bacterial contamination hypothesis: a new concept in endometriosis. Reprod Med Biol. 2018;17(2):125–33.\nGuo R, Chen LH, Xing C, Liu T. Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br J Anaesth. 2019;123(5):637–54.\nErvin SM, Li H, Lim L, Roberts LR, Liang X, Mani S, Redinbo MR. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019;294(49):18586–99.\nJiang I, Yong PJ, Allaire C, Bedaiwy MA. Intricate connections between the microbiota and endometriosis. Int J Mol Sci. 2021;22(11):5644.\nWells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, P Tugwell The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: URL:https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp accessed August 1, 2023\nChen C, Song X, Wei W, Zhong H, Dai J, Lan Z, Li F, Yu X, Feng Q, Wang Z, Xie H, Chen X, Zeng C, Wen B, Zeng L, Du H, Tang H, Xu C, Xia Y, Xia H, Yang H, Wang J, Wang J, Madsen L, Brix S, Kristiansen K, Xu X, Li J, Wu R, Jia H. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun. 2017;8(1):875.\nLin Q, Duan H, Wang S, Guo Z, Wang S, Chang Y, Chen C, Shen M, Shou H, Zhou C. Endometrial microbiota in women with and without adenomyosis: a pilot study. Front Microbiol. 2023;20(14):1075900.\nChen S, Gu Z, Zhang W, Jia S, Wu Y, Zheng P, Dai Y, Leng J. Microbiome of the lower genital tract in Chinese women with endometriosis by 16s-rRNA sequencing technique: a pilot study. Ann Transl Med. 2020;8(21):1440.\nChao X, Liu Y, Fan Q, Shi H, Wang S, Lang J. The role of the vaginal microbiome in distinguishing female chronic pelvic pain caused by endometriosis/adenomyosis. Ann Transl Med. 2021;9(9):771.\nKunaseth J, Waiyaput W, Chanchaem P, Sawaswong V, Permpech R, Payungporn S, Sophonsritsuk A. Vaginal microbiome of women with adenomyosis: a case-control study. PLoS One. 2022;17(2):e0263283.\nKers JG, Saccenti E. The power of microbiome studies: some considerations on which alpha and beta metrics to use and how to report results. Front Microbiol. 2022;3(12):796025.\nTakada K, Melnikov VG, Kobayashi R, Komine-Aizawa S, Tsuji NM, Hayakawa S. Female reproductive tract-organ axes. Front Immunol. 2023;31(14):1110001.\nCastro J, Alves P, Sousa C, Cereija T, França Â, Jefferson KK, Cerca N. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates. Sci Rep. 2015;26(5):11640.\nMuraoka A, Suzuki M, Hamaguchi T, Watanabe S, Iijima K, Murofushi Y, Shinjo K, Osuka S, Hariyama Y, Ito M, Ohno K, Kiyono T, Kyo S, Iwase A, Kikkawa F, Kajiyama H, Kondo Y. Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. Sci Transl Med. 2023;15(700):eadd1531.\nAcknowledgements\nThe authors would like to acknowledge librarian Ariel Pomputius (AP) for assisting with the systematic review search. Additionally, we would like to thank Prof. Christian Jobin and Dr. Javier Tamargo for providing resources.\nFunding\nNone.\nAuthor information\nAuthors and Affiliations\nContributions\nAQ, TM, and MDD wrote the protocol; AP conducted the systematic search; TM and MDD independently screened articles, selected eligible studies, and extracted data. TM and MDD consulted AQ to resolve differences of opinion for eventual consensus. AQ, TM, MDD, and MWD collaborated to interpret the results and write the paper.\nCorresponding author\nEthics declarations\nEthics Approval\nNot applicable.\nConsent to Participate\nNot applicable.\nConsent for Publication\nAll authors consent to the publication of the manuscript.\nConflicts of Interest/Competing Interests\nAQ receives research support from the Bristol-Myers Squibb Foundation. MDD, MWD, TM do not have any conflicts of interest.\nAdditional information\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nPrior Presentation: Data in the study has not been previously published or presented.\nSupplementary Information\nBelow is the link to the electronic supplementary material.\nRights and permissions\nAbout this article\nCite this article\nDantzler, M.D., Miller, TA., Dougherty, M.W. et al. The Microbiome Landscape of Adenomyosis: A Systematic Review. Reprod. Sci. 32, 251–260 (2025). https://doi.org/10.1007/s43032-024-01766-7\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s43032-024-01766-7","source_license":"CC0","license_restricted":false}